ADJUVANT
Clinical trials for ADJUVANT explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT trials appear
Sign up with your email to follow new studies for ADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop lung Cancer's return after surgery
Disease control Recruiting nowThis study is testing whether adding a new drug called zipalertinib to standard chemotherapy after lung cancer surgery works better than chemotherapy alone. It's for people with early-stage lung cancer who have specific, less common genetic changes in their tumor. The goal is to …
Matched conditions: ADJUVANT
Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope to stop liver Cancer's return after surgery
Disease control Recruiting nowThis study is testing if adding a procedure called TACE after curative liver cancer surgery helps prevent the cancer from coming back. It will involve 442 patients who have had surgery but are at high risk of recurrence. Patients will be randomly assigned to either receive the TA…
Matched conditions: ADJUVANT
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC